Low Dose Metronomic Cyclophosphamide and Methotrexate Chemotherapy in Combination With Aspirin in Patients With Stage II-III Breast Cancer Who Fail to Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aspirin; Cyclophosphamide; Methotrexate
- Indications Breast cancer
- Focus Adverse reactions
- 12 Jun 2012 New trial record
- 05 Jun 2012 Biomarkers information updated